What are the differences between Molecular circulating tumor DNA (ctDNA) testing and minimal residual disease (MRD) testing?

Now presenting Dr. @Joshua_Reuss!

#LungCancer #TargetedTherapies #TrueOrFalse #Molecularprofiling #MRDTesting #ctDNATesting

Molecular Profiling of Fungi using specific primers Accurate information about fungal identification is very important in various fields, such as medical, agronomic, environmental, and industrial. Traditional morphological and biochemical-based assays ...

Molecular Profiling of Fungi using specific primers

#Fungalidentification
#Molecularprofiling
#PCR-basedmethods
#NGs
#Specificprimers

kauj.researchcommons.org/jmealas/vol3...

What is the potential for #MolecularProfiling to refine surgical and #radiotherapy decision-making in #meningioma?

Read the recent study in @NatureMedicine:

go.nature.com/3GygVIj

Combined genomic and molecular analysis defines prognostic markers of relapse in stage IA-IC1 clear cell ovarian carcinoma Clear cell ovarian carcinoma (CCOC) is generally associated with a favourable prognosis, however up to 30 % of low-stage cases relapse within five years. The benefit of adjuvant chemotherapy in early-...

New Publication:

Combined genomic and molecular analysis defines prognostic markers of relapse in stage IA-IC1 clear cell ovarian carcinoma

@uoe-igc.bsky.social

#OvarianCarcinoma #MolecularProfiling

www.gynecologiconcology-online.net/article/S009...

Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma Justin Z. Wang, Vikas Patil, Alexander P. Landry, Chloe Gui, Andrew Ajisebutu, Jeff Liu, Olli Saarela, Stephanie L. Pugh, Minhee Won, Zeel Patel, Rebeca Yakubov, Ramneet Kaloti, Christopher Wilson, Aaron Cohen-Gadol, Mohamed A. Zaazoue, Ghazaleh Tabatabai, Marcos Tatagiba, Felix Behling, Damian A. Almiron Bonnin, Eric C. Holland, Tim J. Kruser, Jill S. Barnholtz-Sloan, Andrew E. Sloan, Craig Horbinski, Silky Chotai, Lola B. Chambless, Andrew Gao, Alexander D. Rebchuk, Serge Makarenko, Stephen Yip, Felix Sahm, Sybren L. N. Maas, Derek S. Tsang, The International Consortium on Meningiomas (ICOM), C. Leland Rogers, Kenneth Aldape, Farshad Nassiri & Gelareh Zadeh

This study, using retrospective data on 2,824 #meningiomas, highlights the potential for #MolecularProfiling to refine #surgical and #radiotherapy decision-making.

Read more: go.nature.com/3GygVIj

Vivek Subbiah: Why Every Rare Cancer Patient Deserves Molecular Profiling? - OncoDaily Vivek Subbiah: Why Every Rare Cancer Patient Deserves Molecular Profiling? / Bettina Ryll, Branko Cuglievan, cancer, clinical trials, FDA, Howard A. Burris

Why Every Rare Cancer Patient Deserves Molecular Profiling? - Vivek Subbiah
@viveksubbiah.bsky.social

oncodaily.com/insight/vive...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #RareCancers #MolecularProfiling

Ashish Kamat: Molecular Profiling of 99 Cases of Micropapillary Urothelial Carcinoma - OncoDaily Ashish Kamat: Molecular Profiling of 99 Cases of Micropapillary Urothelial Carcinoma / Arlene Siefker-Radtke, Ashish Kamat, Ashish M. Kamat, Bogdan Czerniak,

Molecular Profiling of 99 Cases of Micropapillary Urothelial Carcinoma - Ashish Kamat
@ashishkamatmd.bsky.social

oncodaily.com/science/mole...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #UrothelialCarcinoma #MolecularProfiling #BladderCancer